Drug intelligence / Profile preview

penicillin VK + haloperidol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

This is a combination drug consisting of two active pharmaceutical ingredients: - **Penicillin VK (Penicillin V Potassium)** is a narrow-spectrum beta-lactam antibiotic used primarily to treat infections caused by susceptible gram-positive bacteria, such as streptococcal infections. It works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. - **Haloperidol** is a high-potency first-generation (typical) antipsychotic agent used mainly for the treatment of schizophrenia, acute psychosis, Tourette syndrome, and severe behavioral disorders. It acts primarily through strong antagonism of dopamine D2 receptors in the brain's mesolimbic and mesocortical pathways. Haloperidol also has antagonist effects on Sigma-1 receptors and can induce apoptosis in certain cells. The combination would theoretically provide both antibacterial activity from penicillin VK and antipsychotic effects from haloperidol but there is no standard or approved combined formulation known under this exact name.

Other names
penicillin V potassium and haloperidol
02

Targets

DRD2 (Dopamine D2 Receptor)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on penicillin VK + haloperidol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on penicillin VK + haloperidol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call